Bioorganic and Medicinal Chemistry Letters p. 2574 - 2579 (2008)
Update date:2022-08-04
Topics:
Verbist, Bie M.P.
De Cleyn, Michel A.J.
Surkyn, Michel
Fraiponts, Erwin
Aerssens, Jeroen
Nijsen, Marjoleen J.M.A.
Gijsen, Harrie J.M.
A novel series of benzimidazole CB2-receptor agonists was synthesized and the structure-activity relationship explored. The results showed agonistic activities with an EC50 up to 0.5 nM and excellent selectivity (>4000-fold) over the CB1 receptor. The size of the substituent on the 2-position determined the level of agonism, ranging from inverse agonism to partial agonism to full agonism, which was more pronounced for the rat CB2 receptor. A wide variation of sulfonyl substituents at the benzimidazole 5-position was tolerated, which was used to optimize the drug-like properties. This resulted into lead compound 14j that can be used to investigate the potential of a selective, peripherically acting CB2 agonist. The in vitro profile of key compounds is displayed using pie bar charts (VlaaiVis).
View MoreTianjin Jingye Fine Chemicals Co., Ltd.
Contact:+86-15722078107; +86-22-26911407
Address:Bohua Fine Chemicals Base of Petrochemical Industry Park, Nanhuan Road, Dagang District, Tianjin, 300271, P. R. China
ShangHai Original Economy-Trade Develop Co.,Ltd.,
Contact:86-21-68552131
Address:shanghai
Suzhou Lixin Pharmaceutical Co., Ltd.
Contact:86-512-88169812
Address:21 Tangxi Road, Suzhou New District, Suzhou 215151
Anhui Qingyun Pharmaceutical and Chemical Co.,Ltd
Contact:+86-551-63633067
Address:Shuangfeng Road Hefei Anhui
zhuzhou zhongle chemical co. ltd.
Contact:+86-0731 28228409
Address:Zhuzhou, Hunan, China
Doi:10.1021/ja01605a022
(1956)Doi:10.1016/j.jorganchem.2008.01.046
(2008)Doi:10.1016/j.ejmech.2009.12.068
(2010)Doi:10.1080/00397910701861198
(2008)Doi:10.1021/jm00278a025
(1972)Doi:10.1002/ejoc.200700986
(2008)